Logo image of 1CVA.MI

CLEVELAND-CLIFFS INC (1CVA.MI) Stock Fundamental Analysis

BIT:1CVA - Euronext Milan - US1858991011 - Common Stock - Currency: EUR

6.206  -1.6 (-20.52%)

Fundamental Rating

2

1CVA gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 39 industry peers in the Metals & Mining industry. Both the profitability and financial health of 1CVA have multiple concerns. 1CVA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

1CVA had negative earnings in the past year.
1CVA had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: 1CVA reported negative net income in multiple years.
Of the past 5 years 1CVA 4 years had a positive operating cash flow.
1CVA.MI Yearly Net Income VS EBIT VS OCF VS FCF1CVA.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

1.2 Ratios

With a Return On Assets value of -3.60%, 1CVA is not doing good in the industry: 74.36% of the companies in the same industry are doing better.
1CVA's Return On Equity of -11.31% is on the low side compared to the rest of the industry. 1CVA is outperformed by 79.49% of its industry peers.
Industry RankSector Rank
ROA -3.6%
ROE -11.31%
ROIC N/A
ROA(3y)1.93%
ROA(5y)4.16%
ROE(3y)3.63%
ROE(5y)12.18%
ROIC(3y)N/A
ROIC(5y)N/A
1CVA.MI Yearly ROA, ROE, ROIC1CVA.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200

1.3 Margins

1CVA's Gross Margin of 0.36% is on the low side compared to the rest of the industry. 1CVA is outperformed by 87.18% of its industry peers.
1CVA's Gross Margin has declined in the last couple of years.
1CVA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 0.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-74.57%
GM growth 5Y-58.3%
1CVA.MI Yearly Profit, Operating, Gross Margins1CVA.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

2

2. Health

2.1 Basic Checks

1CVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
1CVA has less shares outstanding than it did 1 year ago.
The number of shares outstanding for 1CVA has been increased compared to 5 years ago.
Compared to 1 year ago, 1CVA has a worse debt to assets ratio.
1CVA.MI Yearly Shares Outstanding1CVA.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
1CVA.MI Yearly Total Debt VS Total Assets1CVA.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

Based on the Altman-Z score of 1.25, we must say that 1CVA is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.25, 1CVA is not doing good in the industry: 71.79% of the companies in the same industry are doing better.
A Debt/Equity ratio of 1.11 is on the high side and indicates that 1CVA has dependencies on debt financing.
1CVA has a worse Debt to Equity ratio (1.11) than 82.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF N/A
Altman-Z 1.25
ROIC/WACCN/A
WACC8.39%
1CVA.MI Yearly LT Debt VS Equity VS FCF1CVA.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 2.08 indicates that 1CVA has no problem at all paying its short term obligations.
The Current ratio of 1CVA (2.08) is better than 76.92% of its industry peers.
1CVA has a Quick Ratio of 2.08. This is a bad value and indicates that 1CVA is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.55, 1CVA is not doing good in the industry: 82.05% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 2.08
Quick Ratio 0.55
1CVA.MI Yearly Current Assets VS Current Liabilites1CVA.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

4

3. Growth

3.1 Past

1CVA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -222.33%.
1CVA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -12.78%.
1CVA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 57.33% yearly.
EPS 1Y (TTM)-222.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1740%
Revenue 1Y (TTM)-12.78%
Revenue growth 3Y-2.1%
Revenue growth 5Y57.33%
Sales Q2Q%-15.4%

3.2 Future

1CVA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 36.03% yearly.
1CVA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.94% yearly.
EPS Next Y46.9%
EPS Next 2Y52.89%
EPS Next 3Y36.03%
EPS Next 5YN/A
Revenue Next Year4.66%
Revenue Next 2Y5.02%
Revenue Next 3Y4.96%
Revenue Next 5Y1.94%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
1CVA.MI Yearly Revenue VS Estimates1CVA.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5B 10B 15B 20B
1CVA.MI Yearly EPS VS Estimates1CVA.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

1CVA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year 1CVA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
1CVA.MI Price Earnings VS Forward Price Earnings1CVA.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1CVA indicates a slightly more expensive valuation: 1CVA is more expensive than 76.92% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 24.17
1CVA.MI Per share data1CVA.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

A more expensive valuation may be justified as 1CVA's earnings are expected to grow with 36.03% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y52.89%
EPS Next 3Y36.03%

More info and screens

0

5. Dividend

5.1 Amount

1CVA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CLEVELAND-CLIFFS INC

BIT:1CVA (5/9/2025, 7:00:00 PM)

6.206

-1.6 (-20.52%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-24 2025-02-24/amc
Earnings (Next)05-07 2025-05-07/amc
Inst Owners74.09%
Inst Owner ChangeN/A
Ins Owners1.52%
Ins Owner ChangeN/A
Market Cap3.07B
Analysts69.41
Price Target11.69 (88.37%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-69.98%
Min EPS beat(2)-90.92%
Max EPS beat(2)-49.04%
EPS beat(4)1
Avg EPS beat(4)-14.67%
Min EPS beat(4)-90.92%
Max EPS beat(4)100%
EPS beat(8)4
Avg EPS beat(8)2.54%
EPS beat(12)5
Avg EPS beat(12)-5.94%
EPS beat(16)6
Avg EPS beat(16)-9.78%
Revenue beat(2)0
Avg Revenue beat(2)-4.23%
Min Revenue beat(2)-5.15%
Max Revenue beat(2)-3.31%
Revenue beat(4)0
Avg Revenue beat(4)-3.82%
Min Revenue beat(4)-5.15%
Max Revenue beat(4)-3.12%
Revenue beat(8)2
Avg Revenue beat(8)-1.8%
Revenue beat(12)4
Avg Revenue beat(12)-0.94%
Revenue beat(16)5
Avg Revenue beat(16)-1.19%
PT rev (1m)-12.43%
PT rev (3m)-12.43%
EPS NQ rev (1m)-365.79%
EPS NQ rev (3m)-365.79%
EPS NY rev (1m)-469.5%
EPS NY rev (3m)-469.5%
Revenue NQ rev (1m)-4.03%
Revenue NQ rev (3m)-4.03%
Revenue NY rev (1m)-1.52%
Revenue NY rev (3m)-1.52%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.18
P/FCF N/A
P/OCF 32.48
P/B 0.51
P/tB 0.92
EV/EBITDA 24.17
EPS(TTM)-1.13
EYN/A
EPS(NY)-0.6
Fwd EYN/A
FCF(TTM)-1.07
FCFYN/A
OCF(TTM)0.19
OCFY3.08%
SpS34.92
BVpS12.13
TBVpS6.78
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.6%
ROE -11.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 0.36%
FCFM N/A
ROA(3y)1.93%
ROA(5y)4.16%
ROE(3y)3.63%
ROE(5y)12.18%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-74.57%
GM growth 5Y-58.3%
F-Score4
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF N/A
Debt/EBITDA 16.52
Cap/Depr 73.08%
Cap/Sales 3.62%
Interest Coverage N/A
Cash Conversion 23.49%
Profit Quality N/A
Current Ratio 2.08
Quick Ratio 0.55
Altman-Z 1.25
F-Score4
WACC8.39%
ROIC/WACCN/A
Cap/Depr(3y)76.89%
Cap/Depr(5y)95.94%
Cap/Sales(3y)3.55%
Cap/Sales(5y)4.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-222.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1740%
EPS Next Y46.9%
EPS Next 2Y52.89%
EPS Next 3Y36.03%
EPS Next 5YN/A
Revenue 1Y (TTM)-12.78%
Revenue growth 3Y-2.1%
Revenue growth 5Y57.33%
Sales Q2Q%-15.4%
Revenue Next Year4.66%
Revenue Next 2Y5.02%
Revenue Next 3Y4.96%
Revenue Next 5Y1.94%
EBIT growth 1Y-164.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year334.37%
EBIT Next 3Y79.36%
EBIT Next 5Y47.39%
FCF growth 1Y-136.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-95.37%
OCF growth 3Y-66.47%
OCF growth 5Y-28.65%